Azeria Therapeutics competitorsClear all

Azeria Therapeutics's top competitors include OncoTherapy Science and Immutep.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Azeria Therapeutics
Azeria Therapeutics
Azeria Therapeutics is a company that develops a cancer drug intended to aid in the treatment of breast and prostate cancer patients.
OncoTherapy Science
OncoTherapy Science
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
Immutep
Immutep
Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.
Founding Date
Founding Date
2017
Founding Date
2001
Founding Date
2001
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, GB HQ
Locations
Kawasaki, JP HQ
Locations
Sydney, AU HQ
Sydney, AU
The Rocks, AU
Orsay, FR
Berlin, DE
Leipzig, DE
Employees
Employees
3
Employees
66
Employees
2427% decrease

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥332.5m (FY, 2021)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
(¥263.9m) (FY, 2021)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
¥68.6m (FY, 2021)
Gross profit
$3.9m (FY, 2021)
Net income
Net income
N/A
Net income
(¥1.6b) (FY, 2021)
Net income
($29.9m) (FY, 2021)
For sources of this data, please see the company profile

View company profiles

OncoTherapy Science
HQ
Kawasaki, JP
Employees
66

OncoTherapy Science is a company engaged in research and development of cancer therapeutics.

View company
Immutep
HQ
Sydney, AU
Employees
24↓ 27% decrease

Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.

View company